Veradigm | MDRX - Current Liabilities


Veradigm reported $230.31M in Current Liabilities for its fiscal quarter ending in December of 2022.





Current Liabilities Change Date
Alcidion AUD 22.33M 1.47M Dec/2025
Ambu A/S DKK 1.03B 33M Mar/2026
Amplifon EUR 738.21M 852.39M Jun/2026
Cardinal Health USD 41.99B 1.33B Mar/2026
Centene USD 40.76B 714M Jun/2026
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Cigna USD 55.56B 2.96B Jun/2026
Coloplast 7.93B 1.42B Dec/2025
Convatec Group USD 512.3M 130.7M Dec/2024
CVS Health USD 86.41B 2.29B Mar/2026
Diasorin EUR 555.45M 289.08M Jun/2025
Elevance Health USD 44.25B 1.06B Jun/2026
General Electric Aerospace USD 40.43B 403M Jun/2026
Gulf Medical Proj AED 171.09M 18.53M Dec/2025
Humana USD 21.51B 5.16B Mar/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
Laboratory Of America USD 2.12B 516.4M Jun/2026
Maximus USD 681.69M 73.64M Mar/2026
McKesson USD 67.02B 1.11B Mar/2026
Med Life RON 929.7M 46.35M Mar/2026
Molina Healthcare USD 7.7B 488M Jun/2026
Omnicell USD 447.44M 35.61M Jun/2026
Oriola-kd EUR 649.7M 140.4M Mar/2026
Owens Minor USD 1.2B 256.03M Mar/2026
Quest Diagnostics USD 1.79B 389M Jun/2026
Rede D'or Sao Luiz BRL 19.13B 146.56M Mar/2026
Siemens Healthineers EUR 12.87B 11M Jun/2026
Sonova Holding CHF 1.5B 303M Jun/2025
Supermax Corporation Bhd MYR 335.77M 15.65M Mar/2026
UnitedHealth USD 114.12B 773M Mar/2026
Veeva Systems USD 1.7B 64.71M Mar/2026
Veradigm USD 230.31M 22.78M Dec/2022
Xerox USD 3.2B 20M Mar/2026